The present work explores bioactive glass nanoparticles (BGNPs) and developed strontium-doped nanoparticles (BGNPsSr), envisioning orthopedic strategies compatible with vascularization. The nanoparticles were synthesized by sol-gel, achieving a diameter of 55 nm for BGNPs and of 75 nm for BGNPsSr, and the inclusion of strontium caused none structural alteration. The nanoparticles exhibited high cytocompatibility for HUVECs and SaOS-2.
INTRODUCTION
Traumatic injuries, infections or tumor resections can originate critical-sized bone defects that cannot regenerate per se. The current treatments using autografts or allografts are limited due to recurrent second site surgery, donor site morbidity, limited availability, immunological rejection, disease transmission, high costs, and limited integration with natural bone. In this regard, bioactive glasses find use as a standard alternative for allografts in orthopedic treatments due to their excellent tissue integration. [1] [2] Upon implantation into bone defects, they can induce a bone-like apatite layer on their surface, stimulate osteogenesis, angiogenesis, and promote high osteoinduction rates. [3] [4] These features are crucial for an interfacial bonding between the bone and the implant, leading to osteointegration. 5 However, their outcome is unsatisfactory compared to biological grafts, and bone tissue regeneration requires materials that mimic the natural bone nanostructured niche. 6 It was also found that the communications between cells and biomaterials occur on the nanoscale. 7 At this level, several interrelated properties regulate the cell-biomaterial interactions such as nanotopography, surface area, energy, hydrophilicity, or chemical composition. [8] [9] These features govern the contacts with proteins, modulate cell adhesion, spreading, proliferation and, at last, they affect the long-term functionality of implants. [10] [11] Thus, in recent years, nanotechnology tools have been explored to develop bioactive glass nanoparticles (BGNPs). 12 4 and inorganic phases compose the extracellular matrices of hard tissues, showing potential for bone tissue engineering and periodontal regeneration. 15 Thus, the nanoparticulate form of bioactive glasses could be an ideal bioactive 'nanocomponent' for bone scaffolds. [16] [17] The ionic constituents of the glass network could enhance the therapeutic performance of bioactive glasses. 18 Therefore, there is a high demand to develop new BGNPs with a tailored chemical composition for broader applications. In this regard, strontium (Sr) has attracted attention due to its therapeutic effects on orthopedics. 19 Physiologically, Sr is a trace element in human hard tissues that can accumulate in the bone and displace calcium in the apatite phase of bone mineral. 20 Moreover, Sr was correlated with an increase of bone compressive strength and, its deficiency has shown detrimental effects in hard tissues. 21 Sr ions could stimulate bone formation and decrease bone resorption both in vitro and in vivo being, therefore, used as a pharmaceutical agent for treatment of osteoporosis. 22 Due to its benefits, Sr has been proposed as a therapeutic ion to be incorporated in several bioactive glasses. 18 Also, Sr-containing bioactive glasses stimulated osteogenic differentiation of periodontal ligament cells, 23 mesenchymal stromal cells, 24 and human bone marrow stromal cells. 25 However, typical compositions of bioactive glasses have several components, e.g. Na, which is a network modifier that lowers the melting point of the glass. 26 Therefore, when considering BGNPs as a reservoir for the delivery of therapeutic ions, more simple compositions are needed. Minimalistic compositions can be synthesized using the sol-gel process as it enables a control of the reaction kinetics. 27 Herein, the compositional flexibility of the sol-gel method was exploited to incorporate strontium (Sr) into ternary based BGNPs in order to improve its biological outcome, without increasing the amount of network modifiers. The developed quaternary strontium doped 5 bioactive glass nanoparticles (BGNPsSr) have been successfully used in nanocomposite bio-inks in the biofabrication of 3D bioactive structures with proven bioactivity. 28 Consequently, an indepth knowledge of this nanoparticles became needed. Therefore, this work aimed to study the physicochemical changes of the strontium incorporation, estimate the viability and cellular functionality of relevant cell types, and evaluate the osteogenic potential of the produced nanoparticles unveiling the possible stimulating effects of released Sr ions on stem cells osteogenic differentiation. For this purpose, osteoblast-like cells (SaOS-2) and endothelial-like cells (HUVECs), will be employed for cytocompatibility studies as they are cell types known to be involved in the physiologically bone regeneration process. Hence, human adipose stem cells (hASCs) will be used to mimic the cellular events of the bone formation process, from the stage of osteoprogenitor cell proliferation to the stages of osteogenic maturation. We hypothesized that the BGNPsSr might be effective in the osteogenesis of cells which ultimately contributes to the successful regeneration of bone defects. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 6
RESULTS AND DISCUSSION

PRODUCTION AND CHARACTERIZATION OF THE NANOPARTICLES
By exploiting the flexibility of the sol-gel method, two types of nanoparticles were produced: ternary nanoparticles (BGNPs), and quaternary strontium-doped nanoparticles (BGNPsSr). The conventional sol-gel process (Stöber method) to produce nanoparticles started with the hydrolysis of Si, Ca, P and Sr precursors. Silicon was introduced through the hydrolysis and condensation of TEOS that occurred in an ethanolic medium in the presence of ammonium water. Calcium nitrate and strontium nitrate respectively supplemented calcium and strontium in the formulation. Diammonium hydrogen phosphate was used to add phosphate. Herein, we also used ammonium water to induce precipitation, combining the traditional sol-gel route with coprecipitation methods. Figure 1A shows the production steps of the sol-gel method and reveal the characteristic morphology of the produced nanoparticles. Even though the particles appear irregularly shaped, no significant differences in the morphology between the two compositions were found ( Figure S1) . Table S1 and Figure S2 ). The abundance of the identified elements is in agreement with the starting compositions of the sol-gel mixtures used for producing the distinct nanoparticles (Table S2) .
Both nanoparticles presented a heterogeneous size that could vary in the range 40-100 nm for BGNPs and from 30-200 nm for BGNPsSr ( Figure 1C) , denoting that the Sr incorporation slight affects the size of the particles. A possible explanation of the larger particle side could reside in the larger ionic radius of Sr (0.112 nm) compared with Ca (0.099 nm) as replacing calcium with Sr on a molar basis lead to more open silicate networks. [29] [30] [31] The nanoparticles composition was 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60   7 also assessed by FTIR spectroscopy (Figure 1D ) that showed the bending and stretching vibrations assigned to the silica network existing in bioactive glasses (460 and 810 and 1030 cm −1 ). The hydro-affinity property of the nanoparticles was investigated by water contact angle and the calculated surface energy (Figure S3 ). Both nanoparticles demonstrated to possess water affinity. This phenomenon could favor the water diffusion and the hydrolytic degradation and the consequent ionic release. Previous studies have reported the water contact angle reduced to 60-65º could favor cell adhesion. 32 
THE BIOACTIVE BEHAVIOR OF THE NANOPARTICLES
Bearing in mind bone tissue applications, the osteoconductive potential of the nanoparticles was evaluated through biomineralization studies (Figure 2A) . The formation of a bone-like apatite layer when the material contacts with SBF is an in vitro bioactivity indicator of the bioglass tissue interaction in an implant scenario ( Table S3 ). 33 One day after immersion in SBF, the samples revealed a rough surface with mineral agglomerates that increased upon 3 days. After 7 days, a dense apatite layer covered the nanoparticles surface showing a typical cauliflower morphology of hydroxyapatite that resulted from the assembling of needle-like crystals ( Figure 2B ). EDS analysis characterized the evolution of the bone-like apatite formation. Herein, the nanoparticles presented a gradual increase in the intensity of both Ca and P peaks accompanied by a steady decrease in the Si and Sr (when applicable) peaks along the 7 days of immersion (Figure 2C and D) . The growth of mineral deposits with increasing incubation time relates to the longer time available for apatite precipitation. Such results indicate the deposition and densification of the apatite layer, agreeing with the SEM images and consistent with previous studies. 34 Also, the ratio of the Ca and P peaks intensity could indicate the calcification extent ( Figure 2E ). Ca/P ratios were close to the hydroxyapatite stoichiometric theoretical value (1.67) just after 3 days. BGNPsSr exhibits lower peaks of P and Ca than the BGNPs which denote that the Sr doping slightly delays the bioactive behavior of the nanoparticles. However, a faster apatite formation was expected, due to an increased ion dissolution rates potentiated by the expanded network of the Sr-doped BGNPs, that could be the result of the larger atomic size of Sr as compared with Ca. 31 Regarding this opposite effect, it is hypothesized that the ion dissolution rates are not the leading difference in apatite formation, as they are intrinsically higher due to the nanosize of both particles, at least at short time points. Therefore, the slight delay on apatite quality at day 1, might be attributed to the increasing Sr content that can slow the bioactive behavior of BGNPsSr, because of the inhibitory effect of Sr on the mineralization kinetics. 35 According to the classic apatite formation mechanism on bioactive glasses, the release and absorption of Ca from SBF onto the electronegative Si-OH groups, formed by hydrolysis of silicate network, attracts PO 4 3from SBF to create nucleation sites. 36 Therefore, the released Sr into solution might interfere with apatite development by competitively binding to PO 4
3compared to Ca. This observation agrees with previous studies showing the formation of carbonated bone-like hydroxyapatite after a similar reaction time of immersion in SBF. 35 FTIR measurements monitored the apatite formation on the surface of the nanoparticles.
The soaked samples also showed the characteristic Si-O-Si bending and stretching vibrations at 460, 810 and 1100 cm −1 , consistent with the silica network present on bioactive glasses ( Figure 2F ). After 7 days, the samples exhibited a vibration band at 1080 cm −1 and a double peak at 607 and 570 cm −1 , due to the stretching vibration of phosphate groups. After 7 days in SBF, the amorphous band (around 600 cm -1 ) evolves into double peak (607 and 570 cm −1 ), due to the stretching vibration of phosphate groups. The formation of the P-O dual band can be a bioactivity marker considered as first evidence of the appearance of crystalline carbonated bone-like hydroxyapatite. 37 These results indicated that the produced nanoparticles induced the growth of hydroxyapatite on their surface.
The quality of apatite formation on top of the BGNPs was also followed using XRD. The apatite formed after 3 and 7 days resembling the typical semi-crystalline hydroxyapatite 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 ( Figure 2G ). 27 The quantitative analysis of the ions during and after SBF immersion was performed to understand the dissolution kinetics of the nanoparticles (Figure 2H and Figure S5 ). The concentrations of both Ca and P decreased as they were consumed for the formation of the apatite bone-like on the nanoparticles surface consistent with EDS results ( Table S4 and Table S5 ). The concentrations of Si ions were increased and then stagnated in the SBF solution.
This may be due to the release of ions, loss of soluble SiO 2 from the surface of the glass specimens to the SBF solution, condensation, and re-polymerization of the SiO 2 -rich layer.
Calcium and phosphorous concentrations then dropped in the SBF solution increasing the silicon ion concentration after 7 days, and this may be due to the formation of an amorphous CaO-P 2 O 5 layer on the surface of the glass sample. 38 Overall, our results indicated that Sr incorporation does not critically influence the mineralization capability of the produced nanoparticles. These results confirm not only the expected bioactive nature of the nanoparticles but also the osteoconductive capacity of the newly developed BGNPsSr. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58 59 60 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 12 immersion in SBF (3 and 7 days). The principal characteristic hydroxyapatite peaks are indicated. The spectra obtained for BGNPs before the immersion in SBF (0 days) are depicted in 
BIOCOMPATIBILITY ASSESSMENT OF THE BIOACTIVE GLASS NANOPARTICLES
In therapy scenario, biomaterials must not cause toxicity to the cells involved in bone regeneration. Along with new bone production, the development of vascularization is necessary to provide oxygen, nutrients, and growth factors essential to cell survival, integration and successful regeneration. This relation is referred as angiogenic-osteogenic coupling. 39 Recent investigations demonstrated that bioactive glasses not merely enhance bone formation but could stimulate angiogenesis, 40 and Sr ions proved advantageous. 41 Therefore, a preliminary biological response of the produced nanoparticles was studied in agglomerated discs using two well-characterized cells lines, SaOS-2 and HUVECs ( Figure 3A) .
The metabolic activity was evaluated using the Alamar blue assay that relies on the cytoplasmic reduction potential of metabolically viable cells. A significant increase in the metabolism was observed up to 7 days of culture for SaOS-2, while no significant impact on metabolic activity was observed for HUVECs, after seeding on the agglomerated nanoparticles ( Figure 3B ). The results also showed an increase in the metabolic activity with the time in culture for both cells lines, regardless of the particles. These findings denote that the produced nanoparticles do not negatively interfere with cell metabolism. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57 58 59 60 Figure 3C shows that cells were evenly distributed over the surface of the agglomerated nanoparticles after 1, 3 and 7 days of culture. After 1 day of culture, the nanoparticles sustained cell attachment, though no statistical significance was found in cell proliferation from 3 to 7 days ( Figure 3D ). Both nanoparticles formulations did not influence the spreading of SaOS-2 ( Figure 3E) . However, both nanoparticles favored the spread of HUVECs in the end of the study period. Images were also processed with a specific software for angiogenesis analysis which can detect pseudo-vascular organization of endothelial cells (see figure S7 ). The results not only demonstrated that the nano-nature of the nanoparticles could enhance cell anchorage and spread, but also that strontium elicits a positive effect on the behavior of angiogenic cells. Interestingly, the BGNPsSr seemed to enhance the response of HUVECs as a rearrangement of cell distribution that could be associated to an eventual tubular structure formation that was observed after 7 days of culture ( Figure 3C and Figure S7 ). This morphology could be an indication of the effect of strontium ions in the angiogenesis process (P<0.03 in the angiogenic descriptors, Table S6 ). This microvascular behavior has been similarly reported for ceramics containing strontium, where the ionic release played a corporative role in stimulating endothelial functions. 42 Besides the positive effect of BGNPsSr on the HUVECs morphology, these results also showed an absence of cytotoxicity of the nanoparticles, reinforcing their appropriateness in tissue engineering applications. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57 58 59 60 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 15 agglomerates based on automated measurement features and analyzed after image processing ( Figure S6) . The data were normalized to the control at first time point for each cell type line. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60   16   GENE AND PROTEIN EXPRESSION TOWARDS OSTEOGENIC COMMITMENT   The combination of biomaterials with stem cells has demonstrated to improve bone healing. Stem cells could show a temporal development similar to in vivo bone formation. 43 Therefore, and considering the previous results, it becomes crucial to evaluate whether the nanoparticles could drive osteogenic differentiation to understand their physiological outcome.
The cellular effect of strontium nanoscaled bioactive glasses has been reported in the literature (Table S7 ). However, studies on the effect of strontium doped bioactive glass nanoparticles in stem cells are still required. The osteogenic potential of the produced nanoparticles was examined on stem cells derived from adipose tissue (Figure 4A) . These cells were chosen as the stem cell source due to its abundance, easy access, nonimmunogenicity, and as it represents a suitable cell type for clinical translation into musculoskeletal regeneration treatments. 44 In this study, the nanoparticles were supplemented in the cell culture medium as a well-dispersed form.
Osteogenic differentiation is a gradual process, characterized by developmental stages, in which alterations in this defined sequence can induce or inhibit differentiation and so bone formation. 45 Therefore, this temporal pattern was assessed by real-time PCR regarding the expression of main osteogenic differentiation genes analyzed at 7, 14, and 21 days. Runt-related transcription factor 2 (RUNX2) affects osteogenic differentiation in the early stages and is considered a key integrator in the signaling cascade as it induces other downstream osteo-related genes such as type I collagen, osteocalcin (OCN), and secreted phosphoprotein 1 (SPP1). 46 The nanoparticles influenced the expression levels of RUNX2 in the initial culture periods, in which, a significant upregulation of RUNX2 occurred at 7 days for all the cultures media. A relationship
with BGNPsSr only appears in the basal and osteogenic medium at 7 days, where the levels were 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 similar to the control in osteogenic medium (Figure 4B) . Also, the extent of RUNX2 expression correlated with the expression of type I collagen, OCN, and SPP1 (P<0.03, Table S14 ). Collagen type I alpha 1 (COL1A1) is expressed in the first periods and downregulated in the succeeding osteoblast differentiation, being necessary for the progress of the bone cell phenotype. 46 The results showed upregulation of COL1A1 expression at 7 days for the hASCs cultured in osteogenic medium and when cells were cultured with BGNPsSr despite the culture medium ( Figure 4C) . This finding denotes that the upregulation levels on the basal and osteoinductive media are similar to the ones ascribed to the osteogenic medium when strontium is present.
Moreover, the BGNPsSr possess higher upregulations levels than BGNPs. Alkaline phosphatase (ALP) is a membrane-bound enzyme linked with osteogenic differentiation and phosphate metabolism. 47 The results showed that both nanoparticles induced an upregulation of ALPL gene in the initial 7 days in all culture media (Figure 4D) . These findings remain consistent with reports that demonstrated reduced levels of ALPL in late-stage cultures. 47 This result suggested that the nanoparticles could enhance the ALPL activity of hASCs absent osteogenic supplements.
Osterix (OSX) is an osteoblast transcription factor essential for osteoblast differentiation and bone formation (OSX knock-out mice lack bone completely). 48 OSX expression was enhanced at 7 days in osteogenic medium and remained similar in the following time points for all media.
However, an upregulation was found for BGNPsSr in basal and osteoinductive media ( Figure 4E) . Studies have reported that only differentiated osteoblasts could express osteocalcin (OCN). 49 Herein, the results showed that only the BGNPsSr upregulated the OCN expression at 7 days in all culture media (Figure 4F) . SPP1 expression increased at 7 days in the presence of both nanoparticles but was only enhanced in osteogenic medium (Figure 4G) . 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 18 Altogether, the upregulation of osteogenic differentiation genes were increased by both types of nanoparticles. However, only the BGNPsSr was capable of significantly upregulating all the selected genes in complete basal conditions. These findings indicate that the BGNPsSr are a strong inducer of stem cells through osteocommmitment, even without osteogenic supplementation. In this regard, the mechanism of strontium on bone formation was reported to involve the Ras/MAPK signaling pathway and the downstream transcription factor RUNX2. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 19 (COL1A1) gene expression. The statistical analysis is represented in 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60   20 The cell metabolic activity (indirectly related to cell viability), and proliferation are relevant parameters in cell response. The MTS assay was used to assess cell metabolism relying on the mitochondrial activity of hASCs. 51 Both nanoparticles supplemented in the cell culture medium did not affect hASCs metabolic activity (Figure 5A) . The spreading of hASCs in the presence of nanoparticles denotes their stem cell biocompatibility. The osteogenic control had a significantly higher metabolic activity than both nanoparticles, which could be due to the higher differentiation of hASCs in the presence of both nanoparticles. Similar phenomena have been previously reported. 52 Clusters of nanoparticles were also observed inside and on the outer surface of the plasma membrane of hASCs (Figure S8) , engulfed by membrane protrusions which might indicate endocytosis (Figure 5B) .
The osteogenic differentiation of hASCs in the presence of particles was also evaluated at the protein level. The expression of bone-specific proteins, osteocalcin (OCN) and osteopontin (OPN), were evaluated by immunofluorescence at 14 and 21 days in either basal or osteogenic media (Figure 5C and D) . The osteoinductive medium was eliminated from this study since the previous results showed no relevant effect on cell behavior (Table S14) . OCN is an early marker of osteogenic differentiation and reported as an osteoblast-specific ECM phosphoprotein known to be involved in cell attachment, proliferation, and in the onset of matrix deposition. 53 OPN is a non-collagenous protein of the bone extracellular matrix (ECM) and is produced by osteoblasts involved in endochondral ossification. 54 The osteogenic markers OCN and OPN were detected in all conditions, and a high protein expression up to day 14 shows bone ECM maturation ( Figure   5E and F) . 55 Page 20 of 36 & Interfaces   1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 21 Overall, the upregulation of genes and the synthesis of the selected proteins were increased by both nanoparticles without requiring osteogenic supplements. These findings further suggest that the particles and their dissolution products are likely influencing the commitment of hASCs toward osteoblast differentiation. It is hypothesized that ions released from the nanoparticles may exert an osteogenic effect by locally modifying the culture medium.
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CONCLUSIONS
In this study, we have demonstrated the biological performance of bioactive glass nanoparticles for osteogenic applications in bone tissue engineering. New nanoparticles doped with strontium ions have been successfully developed, and a comprehensive characterization for regenerative medicine was performed. The produced nanoparticles -BGNPs and BGNPsSrpresented a bioactive behavior, leading to the formation of an apatite layer on the surface when immersed in SBF. Moreover, HUVECs, SaOS-2 and, hASCs kept their viability levels in the presence of both nanoparticles in comparison with cells not exposed to the particles. The
BGNPsSr formulation promoted the angiogenic phenotype of HUVECs. To investigate the ion release effect of BGNPs and BGNPsSr on osteoblast differentiation of hASCs, the gene and proteins expression of early and late osteoblast markers were examined. Overall, the biochemical data showed that the selected genes and proteins were typically expressed throughout the culture period indicating that both nanoparticles represent an adequate support for osteogenic differentiation. The results also show that the partial substitution of Ca for Sr in the nanoparticles is effective on favoring the expression of genes and proteins, indicating these nanoparticles could govern stem cells through osteocommitment, even without osteogenic supplementation.
Therefore, the developed BGNPsSr may be used as biological agents to modulate the behavior of stem cells. These findings open new possibilities for BGNPsSr alone or as additives in a matrix (e.g., scaffolds or hydrogels) avoiding the need of culturing stem cells with typical osteogenic cocktails in cell culture or during the in vivo implantation. Therefore, incorporating Sr into BGNPs can be used to design a new generation of (i) bioactive nanocomposites or (ii) cell 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 25 internalizable ingredient in "scaffold-free" strategies for stem cell modulation in vascularized bone-engineered applications.
METHODS
Bioactive glass nanoparticles preparation:
The preparation of the ternary form of BGNPs followed a described protocol comprising sequential reagent dissolutions that resulted in hydrolysis and polycondensation reactions (Information S1). 27 A similar procedure was followed to obtain Sr-doped BGNPs (BGNPsSr), but in this case, the sol-gel precursor solution contained strontium nitrate (Sigma-Aldrich, see Table S2 ).
In vitro bioactivity study:
The tests were carried out for 1, 3 and 7 days at 37 °C in disc shape agglomerates. Discs of both BGNPs and BGNPsSr, with an approximate weight of 100 mg and ø 4 mm, were produced through a compact and inexpensive hand-driven press (MHP-1, Shimadzu; Germany), ensuring the reproducibility of the operation. The samples were immersed in 30 mL of simulated body fluid (SBF , Table S3 ) under shaking (30 rpm). After removing the samples from SBF, they were rinsed with distilled water, dried at 60 °C for 24 h and kept in desiccators. The preparation of SBF followed the protocol described by Kokubo and Takadama. 33 Elemental and morphological assessment: The nanoparticles were dispersed in 100% ethanol and fixed by mutual conductive adhesive tape. Energy dispersive spectroscopy (EDS;
QUANTAX200 Bruker, Germany) was first performed to analyze the elemental composition of the nanoparticles. A scanning electron microscope (SEM; JSM-6010LV, JEOL, Japan), operated at 15 kV, was used to study the morphology of the nanoparticles produced. Before SEM acquisition, all samples were coated with a thin layer of carbon using a sputter coater (EM 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 26 ACE600, Leica, Germany). Images were taken after short exposure times to ensure no beam damage to the nanoparticles during analysis.
Size distribution: Nanoparticles solutions were prepared at 1 mg mL -1 in ethanol, followed by 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 27 cell lines for preliminary cytocompatibility studies. To investigate any pH changes caused by BGNPs, as has been reported in the literature, 30 the agglomerated discs samples of BGNPs or BGNPsSr (produced as described in the in vitro bioactivity study -Section 3.2) were rinsed with sterile PBS for 24 h. As no significant change in pH was detected over the study period ( Figure   S9 ), the agglomerated discs samples were used for cell culture purposes right after preparation.
The labeling of live cells, the cytoplasm staining, and the metabolic activity protocol is detailed in Information S2. For quantification of cell number and cell area, all images were processed using algorithms developed in ImageJ (version 2.0, NIH, USA) and by using specific routines written by the authors. Briefly, image stacks in the green channel were used as input, and then thresholded, segmented, and measured by features established in the software. Six images per condition were used.
Osteogenic Differentiation: Human adipose stem cells (hASCs) were cultured with bioactive glass nanoparticles dispersed in the medium with and without osteogenic supplements. After isolation and expansion (Information S3), the cells could adhere for 24 h, and the basal medium was replaced with osteoconductive, or osteogenic medium, either containing a dispersion of BGNPs or BGNPsSr at 100 µg mL -1 , as higher doses showed to reduce cell viability and proliferation. 56 For that, sterilized nanoparticles (dry heat at 180 °C for 2 h) were dispersed in an ultrasonic bath in α-MEM medium (with no supplementation) for 5 min, autoclaved, and then supplemented as the basal medium. The osteogenic medium consisted in the basal medium supplemented with 10 mM beta-glycerophosphate (Sigma-Aldrich), 10-8 mM dexamethasone (Sigma-Aldrich), and 50 mg mL -1 l-ascorbic acid 2-phosphate sesquimagnesium salt hydrate (Sigma-Aldrich). The osteoconductive medium was similar to osteogenic medium but without 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 28 dexamethasone supplementation. Cells were then incubated in a humidified environment at 37 °C with 5% CO2 for 7, 14 and 21 days. The upper half of the culture medium was renewed every 3 days to ensure nanoparticles remaining at the bottom of the wells. Cells cultured in basal, osteogenic and osteoconductive media absent nanoparticles were experimental controls (Ctrl). Table S18 . The relative quantification of the target genes was performed using the Livak method. 57 For each sample, the transcripts expression data were normalized to GAPDH, used as the housekeeping gene, and were expressed as fold changes relative to the expression of hASCs 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 29 cultured in basal, osteogenic or osteoconductive medium absent bioactive glass nanoparticles (Ctrl). 
Real
Cell number and metabolic activity:
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